title: Neutrophils in chronic inflammatory airway diseases: can we target them and how?
authors.forename: Y
authors.initials: Y
authors.lastname: Gernez
authors.forename: R
authors.initials: R
authors.lastname: Tirouvanziam
authors.forename: P
authors.initials: P
authors.lastname: Chanez
mesh_terms: D001549:Benzamides / Q000494:pharmacology*; D003503:Cyclobutanes / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D055370:Lung Injury / Q000188:drug therapy* / Q000276:immunology*; D009504:Neutrophils / Q000187:drug effects*; D023063:Receptors, Interleukin-8B / Q000037:antagonists & inhibitors*
chemical_list: C516686:2-hydroxy-N,N-dimethyl-3-(2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-enylamino)benzamide; D001549:Benzamides; D003503:Cyclobutanes; D023063:Receptors, Interleukin-8B